Challenges in the development of new therapies for bronchiectasis

Keyphrases

• New Therapies 100%
• Bronchiectasis 100%
• Cystic Fibrosis 33%
• Clinical Endpoints 33%
• Standard of Care 16%
• Natural History 16%
• Area Cover 16%
• Expert Opinion 16%
• Quality of Life 16%
• Patient Demographics 16%
• Lack of Understanding 16%
• Active Substances 16%
• Chronic Obstructive Pulmonary Disease 16%
• Phase II Trial 16%
• Early Phase Clinical Trials 16%
• New Drug Development 16%
• Preclinical Development 16%
• Animal Disease Models 16%
• Holding Back 16%
• Positive Phase 16%
• Drug Development Program 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Bronchiectasis 100%
• Disease 33%
• Drug Development 33%
• Cystic Fibrosis 33%
• Clinical Trial 16%
• Chronic Obstructive Lung Disease 16%